Fortress Biotech (FBIO) Capital Expenditures (QoQ) (2013 - 2024)
Powered by 
Analysis
Fortress Biotech (FBIO) Capital Expenditures (QoQ) (2013 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -200.00% |
| Dec 31, 2023 | 2,700.00% |
| Sep 30, 2023 | -93.75% |
| Jun 30, 2023 | -11.11% |
| Mar 31, 2023 | -80.22% |
| Dec 31, 2022 | -90.71% |
| Sep 30, 2022 | 219.22% |
| Jun 30, 2022 | -77.04% |
| Mar 31, 2022 | -31.68% |
| Dec 31, 2021 | 324.51% |
| Sep 30, 2021 | -71.24% |
| Jun 30, 2021 | 194.13% |
| Mar 31, 2021 | -21.92% |
| Dec 31, 2020 | 233.97% |
| Sep 30, 2020 | -143.09% |
| Jun 30, 2020 | 123.89% |
| Mar 31, 2020 | -39.33% |
| Dec 31, 2019 | 78.00% |
| Sep 30, 2019 | -23.66% |
| Jun 30, 2019 | 118.33% |